Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 2 , Pages 127-136 , June 2006

Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties

  • Ruchika Nijhara, PhD

      Affiliations

    • University of Maryland, Office of Research and Development, Baltimore, MD, United States
    • ,
  • Krishna Balakrishnan, PhD, MBA

      Affiliations

    • National Institutes of Health, Foundation for Advanced Education in the Sciences, Bethesda, MD 20814, United States
    • Corresponding Author InformationCorresponding author. One Cloister Court, Suite 230 Bethesda, MD 20814.

Received 17 February 2006 ,Accepted 8 April 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1549-9634(06)00045-1

doi: 10.1016/j.nano.2006.04.005

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 2 , Pages 127-136 , June 2006

Article Tools

* Image Usage & Resolution